Previous research suggested that expression of CCNE1 and CCNE2 could synergistically affect the overall survival in hepatocellular carcinoma (HCC) patients and HCC progression requires the expression of any E-cyclin (Sonntag et al. 2018). The gene discussed is CCNE2; the disease is hepatocellular carcinoma.